Both Pfizer and Moderna are launching clinical trials to track health issues — if any — in the years following a diagnosis of vaccine-associated heart problems in teens and young adults.
A study by Canadian researchers published Monday in the Journal of thefound that men younger than 40 who got the Moderna vaccine had the highest risk of heart issues, usually within 21 days after the second dose. The study was observational, meaning it doesn’t prove cause and effect but it is one of only a few studies to compare the risk of myocarditis between the Pfizer and the Moderna vaccines.
It’s unknown how many people with vaccine-associated myocarditis will experience this scarring, he said, noting that about 20% of people with myocarditis linked to viruses go on to experience heart failure. Are some patients at higher risk for heart issues, such as arrhythmias? Dr. Dongngan Truong, a pediatrician at the University of Utah Health, said Pfizer researchers will be trying to determine the factors., will be monitoring participants for five years, according to Truong, a co-lead on the Pfizer study. The Pfizer study will include people who were previously hospitalized with vaccine-associated myocarditis, and it will also follow those who were more recently diagnosed.
, including BQ.1 and BQ.1.1, have begun circulating widely in the U.S., increasing the risk of reinfections, particularly for those who haven't yet received a booster dose.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Colorado’s COVID hospitalizations rise dramatically as flu and RSV spreadHospitalizations for COVID-19 and flu are rising in Colorado at the same time, while a respiratory virus that primarily harms children is already pushing pediatric hospitals to the brink.
続きを読む »
COVID hospitalizations are rising in infants under 6 months, CDC director Walensky saysCovid-19 hospitalizations are rising among babies under 6 months old, CDC Director Rochelle Walensky said, and the agency is urging mothers to get vaccinated to reduce the risk of infection.
続きを読む »
Health officials encourage COVID-19 booster as Thanksgiving nearsWith Thanksgiving two weeks away, public health officials are recommending that Americans get the new COVID-19 booster tweaked to target the most common omicron strain.
続きを読む »
Biden, Xi to meet next week with COVID origin, fentanyl low on agendaThe Nov. 14 Biden-Xi meeting in Bali follows a nosedive in relations between Washington and Beijing due to the coronavirus pandemic and military maneuvers near Taiwan.
続きを読む »
Getting COVID more than once might be even worse than we thoughtA new study finds increased risk of future hospitalization, organ failure, and even death from repeat COVID-19 infections.
続きを読む »